Khan M Z, Stedul H P, Kurjaković N
Research and Development Division, PLIVA d.d., Zagreb, Croatia.
Drug Dev Ind Pharm. 2000 May;26(5):549-54. doi: 10.1081/ddc-100101266.
Tablets containing mesalazine as a model drug were coated using various combinations of two methacrylic acid copolymers, (Eudragit L100 and Eudragit S100) by spraying from aqueous systems. The Eudragit L100-Eudragit S100 (w/w) combinations studied were 1:0, 4:1, 3:2, 1:1, 2:3, 1:4, 1:5, and 0:1. The coated tablets were tested in vitro for their suitability for pH-dependent colon-targeted oral drug delivery. The dissolution profiles of the drug obtained from the studied tablets demonstrate that the release of the drug could be manipulated by changing the Eudragit L100-Eudragit S100 ratios in the combinations within the pH range between 6.0 and 7.0 in which the individual polymers are soluble, and a coating formulation consisting of a combination of the two polymers can overcome the issue of high gastrointestinal (GI) pH variability among individuals. The results also demonstrate the feasibility of using aqueous dispersions of Eudragit L100-Eudragit S100 combinations for coating tablets for colon-targeted delivery of drugs, and that the formulation can be adjusted to deliver drug(s) at any other desirable site of the intestinal region of the GI tract in which pH of the fluid is within the range 6.0 to 7.0. For colon-targeted delivery of drugs, the proposed combination system is superior to tablets coated with either Eudragit L100 or Eudragit S100 alone.
以美沙拉嗪为模型药物的片剂,通过从水性体系中喷雾的方式,使用两种甲基丙烯酸共聚物(尤特奇L100和尤特奇S100)的各种组合进行包衣。所研究的尤特奇L100 - 尤特奇S100(重量比)组合为1:0、4:1、3:2、1:1、2:3、1:4、1:5和0:1。对包衣片剂进行体外测试,以评估其对pH依赖性结肠靶向口服给药的适用性。从所研究的片剂中获得的药物溶出曲线表明,在6.0至7.0的pH范围内(在此pH范围内各聚合物可溶),通过改变组合中尤特奇L100 - 尤特奇S100的比例,可以控制药物的释放,并且由两种聚合物组合而成的包衣制剂可以克服个体间胃肠道(GI)pH值变化较大的问题。结果还证明了使用尤特奇L100 - 尤特奇S100组合的水性分散体包衣片剂用于结肠靶向给药的可行性,并且该制剂可以进行调整,以便在胃肠道肠道区域内任何其他期望的部位(其中流体的pH值在6.0至7.0范围内)释放药物。对于结肠靶向给药,所提出的组合系统优于单独用尤特奇L100或尤特奇S100包衣的片剂。